Transdermal delivery of loratadine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424447, 424448, 424449, A61K 970

Patent

active

049102052

ABSTRACT:
A pharmaceutical composition for the transdermal delivery of loratadine comprising isopropyl myristate and rosemary oil and the method of using such a composition for the treatment of allergic reactions are disclosed.

REFERENCES:
patent: 4560553 (1985-12-01), Zupan
patent: 4659716 (1987-04-01), Villani et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Transdermal delivery of loratadine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal delivery of loratadine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery of loratadine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-793083

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.